Physician

Carey-Walter Franklin Closson, MD

According to 2025 Medicare claims, Carey-Walter Closson, MD (NPI: 1336230416) practices pain management in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Mecklenburg, NC. This provider's primary affiliated billing organization is CAROLINAS PAIN INSTITUTE, PA (NPI: 1376598268; TIN: 47-0939746) and primary practice location at 28211-5055. Closson is affiliated with the Sunflower ACO LLC (ACO ID: A5499), participating under the MSSP model.

Closson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 420 traditional Medicare patients, billed 1,703 HCPCS/CPT codes, and received $170,737 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 1,234 prescription claims across 503 beneficiaries totaling $78,626 in drug costs, led by Belbuca (Buprenorphine Hcl). 2020 DME data shows 11 claims. Open Payments data shows 38 records totaling $1,332. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $590,598 to $170,737. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $43,234 and ending at $78,626. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$350K$700K2015 Medicare payment: $590,598 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $700,449 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $642,430 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $471,571 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $486,933 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $402,929 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $474,818 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $303,690 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $252,643 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $170,737 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201561513,111$590,598
20166298,284$700,449
20175906,991$642,430
20185675,197$471,571
20196075,372$486,933
20204984,314$402,929
20215254,481$474,818
20224682,799$303,690
20234732,595$252,643
20244201,703$170,737

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$39K$79K2015 Drug cost: $43,234 (USD; Tot_Drug_Cst)2016 Drug cost: $31,288 (USD; Tot_Drug_Cst)2017 Drug cost: $27,718 (USD; Tot_Drug_Cst)2018 Drug cost: $42,514 (USD; Tot_Drug_Cst)2019 Drug cost: $33,913 (USD; Tot_Drug_Cst)2020 Drug cost: $23,854 (USD; Tot_Drug_Cst)2021 Drug cost: $30,654 (USD; Tot_Drug_Cst)2022 Drug cost: $42,473 (USD; Tot_Drug_Cst)2023 Drug cost: $36,288 (USD; Tot_Drug_Cst)2024 Drug cost: $78,626 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015178382$43,234
2016199441$31,288
2017171379$27,718
2018175382$42,514
2019187355$33,913
2020155348$23,854
2021162381$30,654
2022216487$42,473
2023241699$36,288
20245031,234$78,626

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$32K$65K2015 Medicare payment: $64,564 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $64,274 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $14,723 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $22,815 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $13,629 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $630 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015116187$64,564
201698121$64,274
20171919$14,723
20183232$22,815
20191717$13,629
2020N/R11$630
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0482Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms138148$195
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more103103$133
64493Injection of lower or sacral spine facet joint using imaging guidance, single level6198$107
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more278434$97
80307Testing for presence of drug, by chemistry analyzers152163$61

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BelbucaBuprenorphine Hcl26740$21,341
Xtampza ErOxycodone Myristate13390$7,571
OxycontinOxycodone Hcl16480$7,557
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1694,953$4,869
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1253,545$2,560

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$1,332SPR Therapeutics, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carey-Walter Franklin Closson, MD?

Tedicare shows public-source Medicare data for Carey-Walter Franklin Closson, MD (NPI 1336230416), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carey-Walter Franklin Closson, MD have ACO affiliation data?

Carey-Walter Franklin Closson, MD is shown with ACO affiliation data for Sunflower ACO LLC (MSSP, ACO ID A5499).

What billing organization is linked to Carey-Walter Franklin Closson, MD?

Carey-Walter Franklin Closson, MD is linked to CAROLINAS PAIN INSTITUTE, PA (billing NPI 1376598268) in the available physician profile data.

Does Carey-Walter Franklin Closson, MD have Open Payments data?

Carey-Walter Franklin Closson, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.